©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatr. May 19, 2021; 11(5): 153-168
Published online May 19, 2021. doi: 10.5498/wjp.v11.i5.153
Published online May 19, 2021. doi: 10.5498/wjp.v11.i5.153
Use of cognitive event-related potentials in the management of psychiatric disorders: Towards an individual follow-up and multi-component clinical approach
Salvatore Campanella, Laboratoire de Psychologie Médicale et d’Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Brussels 1020, Belgium
Author contributions: Campanella S is the sole author of the manuscript.
Conflict-of-interest statement: No relevant conflicts of interest to declare.
Corresponding author: Salvatore Campanella, PhD, Senior Research Associate FNRS, Laboratoire de Psychologie Médicale et d’Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), 4, Place Vangehuchten, Secrétariat de Psychiatrie, Brussels 1020, Belgium. salvatore.campanella@chu-brugmann.be
Received: January 22, 2021
Peer-review started: January 22, 2021
First decision: March 1, 2021
Revised: March 5, 2021
Accepted: April 14, 2021
Article in press: April 14, 2021
Published online: May 19, 2021
Processing time: 110 Days and 22 Hours
Peer-review started: January 22, 2021
First decision: March 1, 2021
Revised: March 5, 2021
Accepted: April 14, 2021
Article in press: April 14, 2021
Published online: May 19, 2021
Processing time: 110 Days and 22 Hours
Core Tip
Core Tip: Despite decades of intense research and many promising results, cognitive event-related potentials (ERPs) have yet to be implemented in daily psychiatric care units as an add-on tool to psychotherapy and medication. I present here the main arguments supporting the notion that ERPs represent a highly suitable tool for performing individual “neuro-cognitive” assessments in psychiatric patients. Such ERP data could help clinicians to specify individual cognitive interventions that will target each patient’s specific needs, thus promoting an “individualized” or “personalized” medicine.